21.90

4.86% 1.015

After Hours: 21.84 -0.06 -0.27%

Summit Therapeutics Inc (SMMT)

Overview News Price History Option Chain Financials Why SMMT Down? Discussions Forecast

Summit Therapeutics Inc stock is traded at $21.90, with a volume of 3.35M. It is up +4.86% in the last 24 hours and up +68.72% over the past month. Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Previous Close:

$20.89

Open:

$20.5

24h Volume:

3.35M

Relative Volume:

0.72

Market Cap:

$16.09B

Revenue:

$956.00K

Net Income/Loss:

$-116.03M

P/E Ratio:

-13.03

EPS:

-1.6811

Net Cash Flow:

$-93.84M

1W Performance:

-0.05%

1M Performance:

+68.72%

6M Performance:

+428.99%

1Y Performance:

+1,071%

1-Day Range:

$20.25

$22.05

1-Week Range:

$19.50

$24.84

52-Week Range:

$1.64

$33.89

Summit Therapeutics Inc Stock (SMMT) Company Profile

Name

Summit Therapeutics Inc

Sector

Healthcare (1203)

Industry

Biotechnology (681)

Phone

650-460-8308

Address

2882 SAND HILL ROAD, MENLO PARK

Employee

105

Twitter

@summitplc

Next Earnings Date

2024-08-06

Latest SEC Filings

SMMT's Discussions on Twitter

Summit Therapeutics Inc Stock (SMMT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-28-18	Downgrade	Janney	Buy → Neutral
May-02-18	Initiated	Janney	Buy
Apr-12-18	Reiterated	Needham	Buy
Feb-13-18	Initiated	BTIG Research	Buy
Jan-04-18	Initiated	SunTrust	Buy
Dec-01-17	Resumed	H.C. Wainwright	Buy
Nov-16-16	Reiterated	RBC Capital Mkts	Outperform
Oct-05-16	Reiterated	Needham	Buy
Sep-16-16	Initiated	H.C. Wainwright	Buy
Mar-30-15	Initiated	Needham	Buy
Mar-30-15	Initiated	Oppenheimer	Outperform

View All

Summit Therapeutics Inc Stock (SMMT) Latest News

04:10 AM

Profund Advisors LLC Has $243,000 Stock Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Sep 29, 2024

Sep 28, 2024

Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics - sharewise

Sep 28, 2024

Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics - MSN

Sep 28, 2024

Eli Lilly and Company (LLY-N) QuotePress Release - The Globe and Mail

Sep 28, 2024

Sep 27, 2024

U.S. Indexes Closed Mixed Friday As Wynn Resorts Led, Summit Therapeutics Lagged - Barron's

Sep 27, 2024

Summit Therapeutics (NASDAQ:SMMT) Shares Gap Down to $22.81 - MarketBeat

Sep 27, 2024

Summit Therapeutics (NASDAQ:SMMT) Shares Gap Down to $22.81 - Defense World

Sep 27, 2024

Summit Therapeutics stock downgraded at Citi (NASDAQ:SMMT) - Seeking Alpha

Sep 27, 2024

Citigroup Lowers Summit Therapeutics (NASDAQ:SMMT) to Neutral - MarketBeat

Sep 27, 2024

Sep 26, 2024

Corbus Pharmaceuticals to Participate in the BMO Capital Markets’ Oncology Summit - Yahoo Finance

Sep 26, 2024

A surfer without a degree is worth $16 billion after his biotech company's stock soared 1,100% in a year - Business Insider

Sep 26, 2024

Is Summit Therapeutics Inc. (SMMT) the Best Performing Stock in 2024? - Insider Monkey

Sep 26, 2024

Is Summit Therapeutics Inc. (SMMT) the Best Performing Stock in 2024? - Yahoo Finance

Sep 26, 2024

Sep 25, 2024

10 Best Performing Stocks in 2024 - Insider Monkey

Sep 25, 2024

Summit Therapeutics (NASDAQ:SMMT) Shares Gap Up on Analyst Upgrade - MarketBeat

Sep 25, 2024

Summit Therapeutics (NASDAQ:SMMT) Given New $40.00 Price Target at Stifel Nicolaus - Defense World

Sep 25, 2024

Summit Therapeutics (NASDAQ:SMMT) Given New $40.00 Price Target at Stifel Nicolaus - MarketBeat

Sep 25, 2024

2 Stocks Up Over 700% in 2024 That Could Soar Even Further - AOL

Sep 25, 2024

2 Stocks Up Over 700% in 2024 That Could Soar Even Further - MSN

Sep 25, 2024

Sep 24, 2024

Long Term Trading Analysis for (SMMT) - Stock Traders Daily

Sep 24, 2024

U.S. Markets Moved Upward Tuesday; Summit Therapeutics Topped Leaders - Barron's

Sep 24, 2024

From Iran to Icon: How Immigrant Maky Zanganeh Became a Self-Made Billionaire in the US - Times Now

Sep 24, 2024

How Iran Immigrant Maky Zanganeh Is Now A Self-Made Billionaire In US - NDTV

Sep 24, 2024

Sep 23, 2024

Stock Traders Buy Large Volume of Summit Therapeutics Call Options (NASDAQ:SMMT) - MarketBeat

Sep 23, 2024

This Stock Is Crushing Nvidia's Performance This Year: Is It Too Late to Buy? - MSN

Sep 23, 2024

Summit Therapeutics, Intel Stir Monday's Afternoon Market Cap Stock Movers - Investing.com

Sep 23, 2024

Summit Therapeutics, Intel Stir Monday's Afternoon Market Cap Stock Movers - Investing.com India

Sep 23, 2024

Summit Therapeutics (NASDAQ:SMMT) Sees Large Volume Increase - MarketBeat

Sep 23, 2024

Stock Traders Buy Large Volume of Summit Therapeutics Call Options (NASDAQ:SMMT) - Defense World

Sep 23, 2024

Summit Therapeutics (NASDAQ:SMMT) Sees Large Volume Increase - Defense World

Sep 23, 2024

Summit Therapeutics Inc: Weathering Stock Market Storms with 15.53B Market Cap - The InvestChronicle

Sep 23, 2024